Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01543581
Title Vismodegib for Treatment of Basal Cell Carcinoma (Erivedge)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Abel Torres, MD
Age Groups: senior | adult
Covered Countries

No variant requirements are available.